CGM Academy for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are:* Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education?* Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education.Participants in the intervention group will:* receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies.* participate in four in-depth online group sessions with diabetes care and education specialists* complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.Participants in the comparison group will:* receive standard education provided to all patients at CHLA* complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
Do I have to stop taking my current medications for this trial?
The protocol does not specify whether you need to stop taking your current medications. However, since the trial focuses on education and monitoring, it's likely you can continue your current medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on education and monitoring rather than changing medication.
What safety data is available for the CGM Academy for Type 1 Diabetes?
The research provided does not directly address safety data specific to the CGM Academy or Continuous Glucose Monitoring Education Program. However, it mentions that there were 281,963 adverse events related to continuous glucose monitors (CGMs) in 2022, as recorded in the FDA database. This indicates that while CGMs are widely used, they are associated with a significant number of adverse events, which could be relevant to the safety considerations of any CGM-related educational program.12345
Is the CGM Academy for Type 1 Diabetes safe for humans?
Is the CGM Academy treatment a promising way to help people with Type 1 Diabetes?
Yes, the CGM Academy treatment is promising because it helps people with Type 1 Diabetes learn how to use continuous glucose monitoring (CGM) technology effectively. This education program supports patients in managing their diabetes better by teaching them how to monitor their blood sugar levels continuously, which can lead to improved health outcomes.23678
How is the CGM Academy treatment different from other treatments for type 1 diabetes?
The CGM Academy treatment is unique because it focuses on educating patients to use continuous glucose monitoring (CGM) technology effectively, providing real-time insights into blood sugar levels, which helps in better managing diabetes compared to traditional methods that only offer occasional glucose snapshots.23678
What data supports the idea that CGM Academy for Type 1 Diabetes is an effective treatment?
The available research shows that educational programs for continuous glucose monitoring (CGM) can be effective for managing type 1 diabetes. For example, a study on adolescents with type 1 diabetes found that an educational intervention helped them make better daily therapy decisions using CGM data. Another study demonstrated that a structured education program improved the time spent in a healthy blood sugar range for children and young people with type 1 diabetes. These findings suggest that CGM Academy, which focuses on education and support, can be an effective treatment for managing type 1 diabetes.368910
What data supports the effectiveness of the treatment CGM Academy, Continuous Glucose Monitoring Education Program, for Type 1 Diabetes?
Research shows that educational programs for continuous glucose monitoring (CGM) can help people with diabetes better manage their condition by improving their understanding and use of CGM technology. For example, structured education programs have been shown to improve glucose control in children and young people with type 1 diabetes.368910
Who Is on the Research Team?
Rebecca Barber, PhD, RN
Principal Investigator
Children's Hospital Los Angeles
Are You a Good Fit for This Trial?
This trial is for young people aged 8-18 with Type 1 Diabetes who've had it for at least 6 months. They must be able to use a smartphone compatible with Dexcom G6 and G7 CGM devices, and participate in virtual visits. They should also speak English or Spanish.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive an interactive workbook and participate in four online group sessions with diabetes care specialists
Standard Education
Participants receive standard education provided to all patients at CHLA
Follow-up
Participants are monitored for changes in glycemic outcomes, diabetes distress, and family responsibility
What Are the Treatments Tested in This Trial?
Interventions
- CGM Academy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Los Angeles
Lead Sponsor